Concepedia

Line Marchand

LM

Statistics

Publications

5

Citations

133

H-Index

5

Active since

2017

Affiliations

ObsEva (Switzerland)(Current)

St George's, University of London

Line Marchand is an author at ObsEva (Switzerland) specializing in reproductive endocrinology, medicine, and pharmacology.

Publications per year

2017–2021

5

Publications

5

The mechanism of action of oxytocin antagonist nolasiban in ART in healthy female volunteers

Piotr Pierzyński, Oliver Pohl, Line Marchand et al. · Reproductive BioMedicine Online · 2021 · 55 citations

, , +4

Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern

Oliver Pohl, Line Marchand, David Bell et al. · Reproductive Sciences · 2020 · 27 citations

, , +14

Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109

Oliver Pohl, Line Marchand, Neil Fawkes et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 23 citations · Full text

, , +17

Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first‐in‐human trial in healthy postmenopausal women

Oliver Pohl, Line Marchand, Jean‐Pierre Gotteland et al. · British Journal of Clinical Pharmacology · 2018 · 18 citations · Full text

, , +11

Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone

Oliver Pohl, Line Marchand, Jean‐Pierre Gotteland et al. · British Journal of Clinical Pharmacology · 2019 · 10 citations · Full text

, , +8

1–5 of 5